Orchard Therapeutics PLC (ORTX)

NASDAQ: ORTX · IEX Real-Time Price · USD
0.584
+0.021 (3.75%)
At close: Jun 30, 2022 4:00 PM
0.589
+0.005 (0.822%)
After-hours: Jun 30, 2022 7:10 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019201820172016
Revenue
1.682.62.512.0800
Revenue Growth (YoY)
-35.45%3.26%21.05%---
Cost of Revenue
0.230.860.810.4200
Gross Profit
1.451.741.711.6500
Selling, General & Admin
54.9164.9957.2231.375.993
Research & Development
86.9893.73117.36205.3232.5316.21
Operating Expenses
141.88158.72174.58236.6938.5119.2
Operating Income
-140.43-156.98-172.87-235.03-38.51-19.2
Interest Expense / Income
2.52.331.54000
Other Expense / Income
0.83-6.6-8.75-5.511.18-0.14
Pretax Income
-143.76-152.71-165.66-229.53-39.69-19.07
Income Tax
0.83-0.73-2.240.970.050.02
Net Income
-144.58-151.98-163.42-230.5-39.74-19.09
Net Income Common
-144.58-151.98-163.42-230.5-39.74-19.09
Shares Outstanding (Basic)
12499932397
Shares Outstanding (Diluted)
12499932397
Shares Change
24.65%6.65%313.31%154.25%24.96%-
EPS (Basic)
-1.17-1.53-1.75-10.22-4.48-2.69
EPS (Diluted)
-1.17-1.53-1.75-10.22-4.48-2.69
Free Cash Flow Per Share
-1.03-1.38-1.83-4.50-3.84-2.08
Gross Margin
86.51%66.97%67.97%79.67%--
Operating Margin
-8384.06%-6049.25%-6879.15%-11321.34%--
Profit Margin
-8631.88%-5856.61%-6503.06%-11102.84%--
Free Cash Flow Margin
-7595.76%-5281.93%-6784.64%-4892.49%--
Effective Tax Rate
-0.58%0.48%1.35%-0.42%-0.13%-0.10%
EBITDA
-138.93-148.38-162.45-228.33-39.39-19.06
EBITDA Margin
-8294.45%-5717.84%-6464.35%-10998.36%--
Depreciation & Amortization
2.3321.681.20.30.01
EBIT
-141.26-150.38-164.12-229.53-39.69-19.07
EBIT Margin
-8433.37%-5795.07%-6531.00%-11056.12%--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).